Lapatinib Ditosylate | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lapatinib Ditosylate
FDA Orange Book

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Lapatinib Ditosylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 10 USDMF, 1 JDMF, 5 EU WC, 1 KDMF, 11 NDC API, 22 Listed Suppliers, $ API Reference Price

30 API Suppliers
10 USDMF
1 JDMF
5 EU WC
1 KDMF
11 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

22 Intermediates Suppliers

22 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

16 FDF Dossiers, 3 FDA Orange Book, 6 Europe, 2 Australia, 1 South Africa, 4 Listed Dossiers

16 FDF Dossiers
3 FDA Orange Book
6 Europe
2 Australia
1 South Africa
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 2 DKSH, 1 Jai Radhe Sales, 2 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 27 Controlled & Modified Release, 22 Solubilizers, 21 Direct Compression, 19 Thickeners and Stabilizers, 17 Disintegrants & Superdisintegrants, 14 Granulation, 11 Lubricants & Glidants, 10 Film Formers & Plasticizers, 10 Co-Processed Excipients, 10 Topical, 9 Parenteral, 5 Empty Capsules, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Coloring Agents, 3 Rheology Modifiers, 3 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents

44 Coating Systems & Additives
31 Fillers, Diluents & Binders
27 Controlled & Modified Release
22 Solubilizers
21 Direct Compression
19 Thickeners and Stabilizers
17 Disintegrants & Superdisintegrants
14 Granulation
11 Lubricants & Glidants
10 Film Formers & Plasticizers
10 Co-Processed Excipients
10 Topical
9 Parenteral
5 Empty Capsules
5 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
4 Coloring Agents
3 Rheology Modifiers
3 Chewable & Orodispersible Aids
2 Surfactant & Foaming Agents

DIGITAL CONTENT

14 NEWS #PharmaBuzz

14 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 6 Finished Drug Prices

2 US Medicaid Prescriptions
6 Finished Drug Prices

MARKET PLACE

1 APIs, 9 FDF Dossiers

1 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 3 Health Canada Patents

1 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 Others

8 Others

$ API Ref.Price (USD/KG) : 2,921 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 1NATCO PHARMA LTD

02 1NOVARTIS

03 1TEVA PHARMS USA INC

filter Dosage Reset all filters

3 All

01 3TABLET;ORAL

filter Regulatory Info Reset all filters

3 All

01 3RX

filter Brand Name Reset all filters

3 All

01 2LAPATINIB DITOSYLATE

02 1TYKERB

filter RLD Reset all filters

3 All

01 2No

02 1Yes

List of Suppliers

Product Main Page

01

NATCO PHARMA LTD

Pharmtech & Ingredients

Not Confirmed

NATCO PHARMA LTD

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

LAPATINIB DITOSYLATE

Brand Name : LAPATINIB DITOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Approval Date : 2020-09-29

Application Number : 203007

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Product Web Link

Digital Content

Corporate PDF

02

NOVARTIS

Pharmtech & Ingredients

Not Confirmed

NOVARTIS

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code : AB

LAPATINIB DITOSYLATE

Brand Name : TYKERB

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Approval Date : 2007-03-13

Application Number : 22059

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

TEVA PHARMS USA INC

Pharmtech & Ingredients

Not Confirmed

TEVA PHARMS USA INC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

LAPATINIB DITOSYLATE

Brand Name : LAPATINIB DITOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Approval Date : 2024-08-16

Application Number : 217968

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?